S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q2 2025

BVF Partners

Period: Q2 2025 Β· Filed: 2025-08-14
View on SEC EDGAR β†—
AUM
$2.80B
Total portfolio value
Positions
44
Reported securities
Top Holding
MLTX
33.3% $932.3M
QoQ Changes
+3 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MLTXMOONLAKE IMMUNOTHERAPEUTICS$932.3M33.31%$47.20$18.95-59.9%
33.3%
KYMRKYMERA THERAPEUTICS INC$240.1M8.58%$43.64$113.51+160.1%
8.6%
RVMDREVOLUTION MEDICINES INC$183.3M6.55%$36.79$189.24+414.4%
6.5%
PTGXPROTAGONIST THERAPEUTICS INC$177.5M6.34%$55.27$131.62+138.1%
6.3%
AXSMAXSOME THERAPEUTICS INC$176.4M6.30%$104.39$244.31+134.0%
6.3%
MIRMMIRUM PHARMACEUTICALS INC$140.5M5.02%$50.89$125.59+146.8%
5.0%
GHRSGH RESEARCH PLC$107.6M3.84%$12.19$27.01+121.6%
3.8%
IONSIONIS PHARMACEUTICALS INC$75.6M2.70%$39.51$81.80+107.0%
2.7%
XOMAXOMA ROYALTY CORPORATION$65.3M2.33%$25.20$43.00+70.6%
2.3%
ZYMEZYMEWORKS INC$54.1M1.93%$12.55$26.31+109.6%
1.9%
SEPNSEPTERNA INC$46.5M1.66%$10.57$34.00+221.7%
1.7%
CELCCELCUITY INC$46.3M1.65%$13.35$107.95+708.6%
1.6%
KURAKURA ONCOLOGY INC$44.7M1.60%$5.77$11.10+92.4%
1.6%
CGEMCULLINAN THERAPEUTICS INC$43.3M1.55%$7.53$17.63+134.1%
1.6%
ACIUAC IMMUNE SA$40.2M1.44%$2.03$2.51+23.6%
1.4%
CDTXCIDARA THERAPEUTICS INC$38.3M1.37%β€”β€”
1.4%
TYRATYRA BIOSCIENCES INC$37.8M1.35%$9.57$30.62+220.0%
1.4%
GPCRSTRUCTURE THERAPEUTICS INC$36.7M1.31%$20.74$53.45+157.7%
1.3%
IMCRIMMUNOCORE HLDGS PLC$32.1M1.15%$31.38$32.50+3.6%
1.1%
GLUEMONTE ROSA THERAPEUTICS INC$25.5M0.91%$4.51$24.21+436.8%
0.9%
FHTXFOGHORN THERAPEUTICS INC$24.9M0.89%$4.70$5.30+12.8%
0.9%
OLMAOLEMA PHARMACEUTICALS INC$22.6M0.81%$4.26$12.64+196.7%
0.8%
CBIOCRESCENT BIOPHARMA INC.$22.4M0.80%$16.14$17.09+5.9%
0.8%
XNCRXENCOR INC$21.5M0.77%$7.86$15.00+90.8%
0.8%
FDMT4D MOLECULAR THERAPEUTICS IN$17.2M0.61%$3.71$13.00+250.4%
0.6%
ELDNELEDON PHARMACEUTICALS INC$17.1M0.61%$2.71$3.95+45.8%
0.6%
ANNXANNEXON INC$16.8M0.60%$2.40$5.46+127.5%
0.6%
PVLAPALVELLA THERAPEUTICS INC NE$15.7M0.56%$22.54$146.76+551.1%
0.6%
EPIXESSA PHARMA INC$14.9M0.53%β€”β€”
0.5%
RPTXREPARE THERAPEUTICS INC$14.4M0.51%β€”β€”
0.5%

Quarter-on-Quarter Activity

Q2 2025 vs. Q1 2025

New Positions (3)

TickerIssuerNotionalSince Filing
IMCRIMMUNOCORE HLDGS PLC$32.1M+3.6%
CBIOCRESCENT BIOPHARMA INC.$22.4M+5.9%
RAPTRAPT THERAPEUTICS INC$9.2M

Exited Positions (8)

TickerIssuerNotional
LKFTGALAPAGOS NV$36.5M
VERVVERVE THERAPEUTICS INC$31.6M
ITOSITEOS THERAPEUTICS INC$18.4M
RAPTRAPT THERAPEUTICS INC$11.3M
THRDTHIRD HARMONIC BIO INC$8.2M
VIGLVIGIL NEUROSCIENCE INC$7.1M
ALLKALLAKOS INC$3.8M
CTMXCYTOMX THERAPEUTICS INC$3.3M

Increased (5)

TickerIssuerNotionalShares Ξ”Since Filing
VSTMVERASTEM INC$1.5M+62.1%
PTGXPROTAGONIST THERAPEUTICS INC$53.0M+24.7%+138.1%
TCRXTSCAN THERAPEUTICS INC$0.8M+6.9%
KYMRKYMERA THERAPEUTICS INC$98.9M+6.6%+160.1%
FDMT4D MOLECULAR THERAPEUTICS IN$2.4M+1.5%+250.4%

Trimmed (6)

TickerIssuerNotionalShares Ξ”Since Filing
CDTXCIDARA THERAPEUTICS INC$18.4M-15.0%
IMUXIMMUNIC INC$-4.4M-14.0%
XOMAXOMA ROYALTY CORPORATION$5.8M-13.2%+70.6%
MIRMMIRUM PHARMACEUTICALS INC$14.5M-1.3%+146.8%
FBRXFORTE BIOSCIENCES INC$3.0M-1.0%
AVTXAVALO THERAPEUTICS INC$-3.2M-0.8%
← Back to Hedge Funds